Teams
Annoviant, Inc.
from Clemson University.Annoviant is advancing patient outcomes in heart disease by delivering innovative, regenerative cardiovascular devices built on its proprietary TxGuard™ soft-tissue technology.
The platform enables durable, off-the-shelf…
Avast Therapeutics
from University of Kentucky.Avast Therapeutics is developing first-in-class, non-invasive peptide therapeutics that safely cross the blood-brain barrier to restore mitochondrial function and protect neurons.
This…
Bluegrass Pharmaceuticals Inc.
from University of Kentucky.Bluegrass Pharmaceuticals develops advanced Lipid Nanoparticles (LNPs) to enhance vaccine efficacy and enable targeted therapeutic delivery.
Kifa Therapeutics, Inc.
from Vanderbilt University.Kifa Therapeutics advances highly selective CNS-kinase inhibitors, starting with a G2019S-LRRK2 therapy for Parkinson’s disease.
Our strategy pairs genetics-based patient selection with…
SelSym Biotech
SelSym Biotech is pioneering hemostasis with SymClot, an innovative platelet-mimetic therapy that promises to dramatically improve patient survival and outcomes by rapidly stopping bleeding after severe trauma and high-risk…
